» Articles » PMID: 36551785

Alterations in Cerebellar Microtubule Cytoskeletal Network in a ValproicAcid-Induced Rat Model of Autism Spectrum Disorders

Overview
Journal Biomedicines
Date 2022 Dec 23
PMID 36551785
Authors
Affiliations
Soon will be listed here.
Abstract

Autism spectrum disorders (ASD) are neurodevelopmental diseases characterised by deficits in social communication, restricted interests, and repetitive behaviours. The growing body of evidence points to a role for cerebellar changes in ASD pathology. Some of the findings suggest that not only motor problems but also social deficits, repetitive behaviours, and mental inflexibility associated with ASD are connected with damage to the cerebellum. However, the understanding of this brain structure's functions in ASD pathology needs future investigations. Therefore, in this study, we generated a rodent model of ASD through a single prenatal administration of valproic acid (VPA) into pregnant rats, followed by cerebellar morphological studies of the offspring, focusing on the alterations of key cytoskeletal elements. The expression (Western blot) of α/β-tubulin and the major neuronal MT-associated proteins (MAP) such as MAP-Tau and MAP1B, MAP2, MAP6 (STOP) along with actin-crosslinking αII-spectrin and neurofilament light polypeptide (NF-L) was investigated. We found that maternal exposure to VPA induces a significant decrease in the protein levels of α/β-tubulin, MAP-Tau, MAP1B, MAP2, and αII-spectrin. Moreover, excessive MAP-Tau phosphorylation at (Ser396) along with key Tau-kinases activation was indicated. Immunohistochemical staining showed chromatolysis in the cerebellum of autistic-like rats and loss of Purkinje cells shedding light on one of the possible molecular mechanisms underpinning neuroplasticity alterations in the ASD brain.

Citing Articles

Molecular switch of the dendrite-to-spine transport of TDP-43/FMRP-bound neuronal mRNAs and its impairment in ASD.

Majumder P, Chatterjee B, Akter K, Ahsan A, Tan S, Huang C Cell Mol Biol Lett. 2025; 30(1):6.

PMID: 39815169 PMC: 11737055. DOI: 10.1186/s11658-024-00684-5.


Will AMPK be a potential therapeutic target for hepatocellular carcinoma?.

Chen G, Li M, Yang J, Zhou Z Am J Cancer Res. 2024; 14(7):3241-3258.

PMID: 39113872 PMC: 11301289. DOI: 10.62347/YAVK1315.


Microtubule Cytoskeletal Network Alterations in a Transgenic Model of Tuberous Sclerosis Complex: Relevance to Autism Spectrum Disorders.

Gassowska-Dobrowolska M, Czapski G, Cieslik M, Zajdel K, Frontczak-Baniewicz M, Babiec L Int J Mol Sci. 2023; 24(8).

PMID: 37108467 PMC: 10138344. DOI: 10.3390/ijms24087303.


Investigation of Phospholipid Differences in Valproic Acid-Induced Autistic Mouse Model Brain Using Mass Spectrometry Imaging.

Jang H, Kwon K, Shin C, Lee G, Moon J, Lee T Metabolites. 2023; 13(2).

PMID: 36837796 PMC: 9966147. DOI: 10.3390/metabo13020178.

References
1.
Conde C, Caceres A . Microtubule assembly, organization and dynamics in axons and dendrites. Nat Rev Neurosci. 2009; 10(5):319-32. DOI: 10.1038/nrn2631. View

2.
Glantz S, Cianci C, Iyer R, Pradhan D, Wang K, Morrow J . Sequential degradation of alphaII and betaII spectrin by calpain in glutamate or maitotoxin-stimulated cells. Biochemistry. 2007; 46(2):502-13. PMC: 2825692. DOI: 10.1021/bi061504y. View

3.
Sandhya T, Sowjanya J, Veeresh B . Bacopa monniera (L.) Wettst ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats. Neurochem Res. 2012; 37(5):1121-31. DOI: 10.1007/s11064-012-0717-1. View

4.
Schneider T, Przewlocki R . Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology. 2004; 30(1):80-9. DOI: 10.1038/sj.npp.1300518. View

5.
Hlushchenko I, Khanal P, Abouelezz A, Paavilainen V, Hotulainen P . ASD-Associated Mutations in Five Actin Regulators Show Both Shared and Distinct Defects in Dendritic Spines and Inhibitory Synapses in Cultured Hippocampal Neurons. Front Cell Neurosci. 2018; 12:217. PMC: 6085419. DOI: 10.3389/fncel.2018.00217. View